Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19. | PLoS One | 2023 | 37751460 | PubTator, text mining | PubMed |
| Hydrogen Deuterium Exchange and other Mass Spectrometry-based Approaches for Epitope Mapping. | Front Anal Sci | 2023 | 37746528 | PubTator, text mining | PubMed |
| The diverse evolutionary histories of domesticated metaviral capsid genes in mammals. | bioRxiv | 2023 | 37745568 | PubTator, text mining | PubMed |
| Constitutive proteins of lumpy skin disease virion assessed by next-generation proteomics. | J Virol | 2023 | 37737587 | PubTator, text mining | PubMed |
| SARS-CoV-2 Variants of Concern and Clinical Severity in the Mexican Pediatric Population. | Infect Dis Rep | 2023 | 37737000 | PubTator, text mining | PubMed |
| Quantitative Polymerase Chain Reaction System for Alongshan Virus Detection. | Methods Protoc | 2023 | 37736962 | PubTator, text mining | PubMed |
| The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody. | Front Cell Infect Microbiol | 2023 | 37736103 | PubTator, text mining | PubMed |
| PKR-mediated stress response enhances dengue and Zika virus replication. | mBio | 2023 | 37732809 | PubTator, text mining | PubMed |
| N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody. | iScience | 2023 | 37731621 | PubTator, text mining | PubMed |
| Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing. | J Extracell Vesicles | 2023 | 37723839 | PubTator, text mining | PubMed |
| Interplay between TRIM7 and antiviral immunity. | Front Cell Infect Microbiol | 2023 | 37719674 | PubTator, text mining | PubMed |
| A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody. | Cell Rep | 2023 | 37715951 | PubTator, text mining | PubMed |
| Nanoscopic Elucidation of Spontaneous Self-Assembly of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Open Reading Frame 6 (ORF6) Protein. | J Phys Chem Lett | 2023 | 37707320 | PubTator, text mining | PubMed |
| COVID severity test (CoST sensor)-An electrochemical immunosensing approach to stratify disease severity. | Bioeng Transl Med | 2023 | 37693054 | PubTator, text mining | PubMed |
| Evolution of transient RNA structure-RNA polymerase interactions in respiratory RNA virus genomes. | Virus Evol | 2023 | 37692892 | PubTator, text mining | PubMed |
| Current state-of-the-art and potential future therapeutic drugs against COVID-19. | Front Cell Dev Biol | 2023 | 37691829 | PubTator, text mining | PubMed |
| Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves. | Int J Mol Sci | 2023 | 37685938 | PubTator, text mining | PubMed |
| Panoramic analysis of coronaviruses carried by representative bat species in Southern China to better understand the coronavirus sphere. | Nat Commun | 2023 | 37684236 | PubTator, text mining | PubMed |
| Endothelial Glycocalyx Injury in SARS-CoV-2 Infection: Molecular Mechanisms and Potential Targeted Therapy. | Mediators Inflamm | 2023 | 37674786 | PubTator, text mining | PubMed |
| Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates. | Sci Adv | 2023 | 37672587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=16